TarrikMohamedZaidMDM.Sc

PubMed

• Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer
  Courtney D Bailey, Rebecca A. Previs, Bryan Fellman, Tarrik M. Zaid, Marilyn Huang, Alaina J. Brown, Ahmed Enbaya, Nyla Balakrishnan, Russell Broaddus, Diane C. Bodurk...> ;International Journal of Gynecological Cancer. 2021 Feb 1
• 29 citations
  Use of social media to conduct a cross-sectional epidemiologic and quality of life survey of patients with neuroendocrine carcinoma of the cervix: A feasibility study
  Tarrik M. Zaid, Jennifer K. Burzawa, Karen Basen-Engquist, Diane C. Bodurka, Lois M. Ramondetta, Jubilee Brown, Michael Frumovitz> ;Gynecologic Oncology. 2014 Jan 1
• 279 citations
  TGF-β Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment
  Tsz-Lun Yeung, Cecilia S. Leung, Kwong Kwok Wong, Goli Samimi, Melissa S. Thompson, Jinsong Liu, Tarrik M. Zaid, Sue Ghosh, Michael J. Birrer, Samuel C. Mok> ;Cancer Research. 2013 Aug 15
• 70 citations
  Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer
  Tarrik M. Zaid, Tsz-Lun Yeung, Melissa S. Thompson, Cecilia S. Leung, Thomas Harding, Ngai Na Co, Rosie S. Schmandt, Suet Ying Kwan, Cristian Rodriguez-Aguay, Gabriel ...> ;Clinical Cancer Research. 2013 Feb 15
• Doctor, what did I do to deserve this?
  Lois M. Ramondetta, Tarrik M. Zaid, Anne Marie Wallace> ;Palliative & Supportive Care. 2011 Dec 1
• 1 citations
  A randomized trial of secondary closure of superficial wound dehiscence by surgical tape or suture.
  Tarrik M. Zaid, Whitney Herring, G. Rodney Meeks> ;Female Pelvic Medicine & Reconstructive Surgery. 2010 Jan 1
• 4 citations
  Growth of Escherichia coli in iron-enriched medium increases HPI catalase activity.
  Tarrik M. Zaid, Trivandrum Sukumaran Nair Srikumar, Ludmil Benov> ;Journal of Biochemistry and Molecular Biology. 2003 Nov 30
• Join now to see all

Journal Articles

• Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer  
  Zaid TM, Yeung TL, Thompson MS, Leung CS, Harding T, Co NN, Schmandt RS, Kwan SY, Rodriguez-Aguay C, Lopez-Berestein G, Sood AK, Wong KK, Birrer MJ, Mok SC, Clin Cancer Res, 1/1/2013
• Identification and characterization of novel Müllerian-specific cancer associated antigen  
  T. Zaid, R. Schmandt, S. Mok, Gynecologic Oncology, 1/1/2013
• Using social media as a research platform for rare gynecologic tumors  
  T. Zaid, J. Burzawa, K. Schmeler, J. Brown, L. Ramondetta, M. Frumovitz, Gynecologic Oncology, 1/1/2013
• The role of interferon-stimulated gene 15 in advanced stage high-grade serous ovarian adenocarcinoma  
  C. Tsai, T. Zaid, C. Co, M. Thompson, T. Yeung, A. Carroll, K. Wong, S. Mok, Gynecologic Oncology, 1/1/2012
• Fibroblast growth factor receptor 4 (FGFR4) expression as a prognostic indicator in high-grade serous ovarian carcinoma (HGSC): Signaling pathway, mechanism, and impli...  
  T. M. Zaid, M. Thompson, K. Wong, T. Yeung, Z. Yeung, D. M. Gershenson, M. J. Birrer and S. C. Mok, Journal of Clinical Oncology, 1/20/2011
• Overexpression of fibroblast growth factor 1 and fibroblast growth factor receptor 4 in high-grade serous ovarian carcinoma: Correlation with survival and implications...  
  Zaid T, Thompson M, Wong K, Yeung T, Yeung Z, Kwan S, Co C, Schmandt R, Birrer M, Mok S, Gynecol Oncol, 1/1/2011
• Overexpression of stromal biglycan correlates with improved survival in patients with high-grade serous ovarian cancer  
  A. Carroll, M.S. Thompson, C. Co, T.M. Zaid, K.K. Wong, T.L. Yeung, R. Schmandt, M.J. Birrer, S.C. Mok, Gynecologic Oncology, 1/1/2011
• Rodney MD A Randomized Trial of Secondary Closure of Superficial Wound Dehiscence by Surgical Tape or Suture  
  Zaid, Tarrik M. MD; Herring, Whitney P. MPH; Meeks, G, Female Pelvic Medicine & Reconstructive Surgery, 1/1/2010
• A randomized trial of secondary closure of suprafascial wound dehiscence by surgical tape or suture  
  Zaid, Tarrik M. MD; Herring, Whitney P. MPH; Meeks, G. Rodney, Journal of Pelvic Medicine & Surgery, 1/1/2009
• The effect of intermittent pneumatic compression on the bone uptake of (99m)Tc-labelled methylene diphosphonate in the lower limb  
  Morris RJ, Elsaid M, Elgazzar AH, Zaid TM, Evans WD, Woodcock JP., Arch Orthop Trauma Surg, 1/1/2005
• Growth of Escherichia coli in iron-enriched medium increases HPI catalase activity  
  Zaid T. Srikumar TS. Benov L, J Biochem Mol Biology, 1/1/2003
• Join now to see all

Books/Book Chapters

• Gynecologic Oncology 
  Chapter: Supportive Care: Nutrition and Growth Factors 
  Ridgway M, Zaid TMEditors: P. Gehrig & A. Secord.Landes Bioscience2011

Abstracts/Posters

• Distribution of disease at the time of interval debulking versus primary tumor reduction in women with primary peritoneal, ovarian, or Fallopian tube carcinoma
  Tarrik M. Zaid, Marilyn Huang, Alaina J. Brown, Nyla Balakrishnan, Hemendra Mhadgut, Navdeep Pal, Caimiao Wei, Russell Broaddus, Diane C. Bodurka, Karen H. Lu, Shannon..., J Clin Oncol, 1/1/2013
• Benefits of neoadjuvant chemotherapy in ovarian, primary peritoneal, or fallopian tube carcinoma
  Alaina J. Brown, Marilyn Huang, Charlotte C. Sun, Tarrik M. Zaid, Nyla Balakrishnan, Hemendra Mhadgut, Karen H. Lu, Shannon Neville Westin, Diane C. Bodurka, J Clin Oncol, 1/1/2013
• Distribution of disease at the time of interval debulking versus primary tumor reduction in women with primary peritoneal, ovarian, or Fallopian tube carcinoma
  Tarrik M. Zaid, Marilyn Huang, Alaina J. Brown, Nyla Balakrishnan, Hemendra Mhadgut, Navdeep Pal, Caimiao Wei, Russell Broaddus, Diane C. Bodurka, Karen H. Lu, Shannon..., American Society of Clinical Oncology (ASCO) 50th Annual Meeting, Chicago, IL, 1/1/2013
• Benefits of neoadjuvant chemotherapy in ovarian, primary peritoneal, or fallopian tube carcinoma
  Alaina J. Brown, Marilyn Huang, Charlotte C. Sun, Tarrik M. Zaid, Nyla Balakrishnan, Hemendra Mhadgut, Karen H. Lu, Shannon Neville Westin, Diane C., American Society of Clinical Oncology (ASCO) 50th Annual Meeting, Chicago, IL, 1/1/2013
• Identification and characterization of novel Müllerian-specific cancer associated antigen
  T. Zaid, R. Schmandt, S. Mok, Society of Gynecologic Oncologists 44th Annual Meeting on Women's Cancer, Los Angeles, CA, 1/1/2013
• Using social media as a research platform for rare gynecologic tumors
  T. Zaid, J. Burzawa, K. Schmeler, J. Brown, L. Ramondetta, M. Frumovitz, Society of Gynecologic Oncologists 44th Annual Meeting on Women's Cancer, Los Angeles, CA, 1/1/2013
• The role of interferon-stimulated gene 15 in advanced stage high-grade serous ovarian adenocarcinoma
  C. Tsai, T. Zaid, C. Co, M. Thompson, T. Yeung, A. Carroll, K. Wong, S. Mok, Society of Gynecologic Oncologists 43rd Annual Meeting on Women's Cancer, Austin, TX, 1/1/2012
• Overexpression of fibroblast growth factor 1 and fibroblast growth factor receptor 4 in high-grade serous ovarian carcinoma: Correlation with survival and implications...
  Zaid T, Thompson M, Wong K, Yeung T, Yeung Z, Kwan S, Co C, Schmandt R, Birrer M, Mok S, 42nd Annual Meeting of the Society of Gynecologic Oncologists, Orlando, FL, 1/1/2011
• Overexpression of stromal biglycan correlates with improved survival in patients with high-grade serous ovarian cancer
  A. Carroll, M.S. Thompson, C. Co, T.M. Zaid, K.K. Wong, T.L. Yeung, R. Schmandt, M.J. Birrer, S.C. Mok, 42nd Annual Meeting of the Society of Gynecologic Oncologists, Orlando, FL, 1/1/2011
• Fibroblast growth factor receptor 4 (FGFR4) expression as a prognostic indicator in high-grade serous ovarian carcinoma (HGSC): Signaling pathway, mechanism, and impli...
  T. M. Zaid, M. Thompson, K. Wong, T. Yeung, Z. Yeung, D. M. Gershenson, M. J. Birrer and S. C. Mok, American Society of Clinical Oncology (ASCO) 47th Annual Meeting, Chicago, IL, 1/1/2011
• Proliferative effects of FGF1 on ovarian cancer cells correlate with FGFR4 over expression and are mediated by MAPK/ERK signaling
  Tarrik Zaid , Melissa S. Thompson, Kwong-kwok Wong, Tsz-Lun Yeung Yeung, Zachary Yeung, Melinda S. Yates, Michael J. Birrer, and Samuel C. Mok, Cancer Research, 1/15/2010
• Identification of FGFR4 in the chromosome 5q31-35 prognostic amplicon as the mediator for FGF1 signaling in high-grad serous ovarian cancer
  Zaid T, Thompson M, Wong K, Yeung T Yeung Z Yates M, Birrer M, Mok S, Gynecol Oncol, 1/1/2010
• Identification of FGFR4 in the chromosome 5q31-35 prognostic amplicon as the mediator for FGF1 signaling in high-grade serous ovarian cancer
  Zaid TM, Thompson MS, Yeung T, Wong KK, Yeung ZP, Yates MS, Birrer MJ, Mok SC, 41st Annual Meeting of the Society of Gynecologic Oncologists, San Francisco, CA, 1/1/2010
• Proliferative effects of FGF1 on ovarian cancer cells correlate with FGFR4 over expression and are mediated by MAPK/ERK signaling
  101st Annual Meeting of the American Association for Cancer Research, 101st Annual Meeting of the American Association for Cancer Research, Washington, DC, 1/1/2010
• Join now to see all

Lectures

• A randomized prospective trial of tape closure and suture closure in superficial wound dehiscence 
  New Orleans, LA - 1/1/2009

Other

• Survey of Risk Behaviors Among Medical Students in Selected Countries in the East Mediterranean Region 
  Zaid TM on behalf of the Kuwait Work Group, World Health Organization Eastern Mediterranean Regional Office Report
  1/1/2005